Grant Skrepnek to Insurance, Health, Reimbursement
This is a "connection" page, showing publications Grant Skrepnek has written about Insurance, Health, Reimbursement.
Connection Strength
0.088
-
Cost-efficacy of imatinib versus allogeneic bone marrow transplantation with a matched unrelated donor in the treatment of chronic myelogenous leukemia: a decision-analytic approach. Pharmacotherapy. 2005 Mar; 25(3):325-34.
Score: 0.061
-
Perspectives for managed care organizations on the burden of multiple sclerosis and the cost-benefits of disease-modifying therapies. J Manag Care Pharm. 2013 Jan-Feb; 19(1 Suppl A):S41-53.
Score: 0.026